1. Examine the concept of confidence
Determine whether confidence in regulatory and clinical evidence is a meaningful research construct and how stakeholders understand it.
Determine whether confidence in regulatory and clinical evidence is a meaningful research construct and how stakeholders understand it.
Examine how existing regulatory, clinical, quality, post-market, vigilance, cybersecurity, governance, and information-management mechanisms maintain or reassess evidence.
Investigate which lifecycle events can materially affect evidence previously relied upon.
Understand how stakeholders become aware of relevant events and how the date and source of awareness are established.
Determine whether later changes can be traced to devices, regulatory entries, clinical or procurement decisions, organisations, or stakeholders that relied upon the original evidence.
Investigate how organisations determine whether an event materially affects earlier decisions.
Explore responsibility for detection, assessment, escalation, communication, action, and closure.
Identify similarities and differences between regulatory systems, healthcare environments, technologies, and professional perspectives.
Determine whether problems are conceptual, regulatory, implementation, information-management, organisational, interoperability, or governance gaps—or are already adequately addressed.
Only if supported by research should later work consider principles, analytical methods, conceptual models, or other approaches.